Global Microcrystalline Cellulose Market is valued at USD 976.4 Million in 2021 and expected to reach USD 1440.3 Million by 2028 with a CAGR of 5.71% over the forecast period.
Microcrystalline Cellulose Market Global Size, Trends, Competitive, Historical & Forecast Analysis to 2022-2028, Increasing growth of pharmaceutical industry and rising consumption of processed food are some of the major factors driving the growth of the Global Microcrystalline Cellulose Market.
Microcrystalline cellulose (MCC) is also known for refined wood pulp and it is used as a substitute for many products while producing food and also used in medicines. The common form of microcrystalline cellulose is used for vitamin supplements or tablets. It is also used in plate analysis for counting viruses, as an alternative to carboxymethylcellulose. Additionally, it is also used as an alternative for unhealthy fat and adds texture to baked food products. Microcrystalline cellulose contains a notable amount of fibers which helps to increase digestion and also acts as a source of nutrients to a variety of nutrients. The growing population and increasing obesity diseases and shifting consumers towards healthy food would drive product consumption.
The ongoing coronavirus (COVID-19) pandemic has altered the face of many industries. The pharmaceutical industry witnessing a significant increase in production due to the Covid-19 pandemic as the increased medicine usage in hospitals around the world which have increased the demand for microcrystalline cellulose in the production of drugs. Many healthcare companies are investing huge in R&D to innovate in efficacious drugs which help to reduce the morbidity and mortality associated with Coronavirus.
The Global Microcrystalline Cellulose market is segmented on the basis of source type, application and region & country level. On the basis of type, the global microcrystalline cellulose market is classified as wood-based and non-wood-based. Based on application, the global microcrystalline cellulose market is segmented as food & beverage, pharmaceutical, cosmetics & personal care, and others.
The regions covered in the Microcrystalline Cellulose market report are North America, Europe, Asia-Pacific, Latin America, and the Rest of the World. On the basis of country level, the market of Global Microcrystalline Cellulose is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.
Microcrystalline Cellulose Market report covers prominent players like:
On July 7th, 2021; DFE Pharma, a provider of pharmaceutical excipient solutions, launched Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). Pharmacel sMCC 90 has been developed as the synergistic solution for challenging oral solid dosage formulations. Among several advancements in formulation science, co-processed excipients are gaining popularity as they offer effective means to rapidly develop products for early human trials, while minimizing the risk to product quality.
On January 13th, 2021; Asahi Kasei's Specialty Solutions SBU built a second plant for microcrystalline cellulose at its Mizushima Works in Kurashiki, Okayama, Japan. Asahi Kasei currently manufacturing Ceolus, microcrystalline cellulose used primarily in pharmaceuticals as tablet binder, in Nobeoka, Miyazaki, Japan. Besides the standard-type product PH series, Ceolus has a lineup of KG series that greatly enhances the compatibility of tablets and the UF series that combines compatibility and flowability. These products provide solutions to a wide range of issues in the production of tablets for pharmaceuticals and supplements.
The increasing usage of microcrystalline cellulose in the pharmaceutical industry as a stabilizer, binder, and disintegrant in the formulation of tablet, ointments, and other topical therapeutic bases is one of the major factors driving the growth of global microcrystalline cellulose market. It is used as an excipient in the pharmaceutical industry. In the pharmaceutical formulation, microcrystalline cellulose used as a blinding agent and key diluent. Microcrystalline cellulose is used in the preparation of drugs such as tablets, capsules, sachets, and so on. The increasing production and demand of pharmaceutical products is further driving the global microcrystalline cellulose market. The developing countries such as Japan, Brazil, and India are the rapidly expanding markets which is expected to drive the microcrystalline cellulose further.
However, there are few alternatives for particular pharmaceutical and food & beverage applications that may restrain the growth of the microcrystalline cellulose market. There are a few products that fare better than microcrystalline cellulose and have very specific applications which can replace the microcrystalline cellulose market. Some of the available products are croscarmellose sodium (CCS), kappa-carrageenan, and carboxymethyl cellulose (CMC). The use of Carboxymethyl cellulose in food & beverages is to stabilize emulsions in food products such as ice creams and baking products. Currently, microcrystalline cellulose is produced by using wood pulp. Production of microcrystalline cellulose using wood is very costly and production of microcrystalline cellulose by using non-wood is cost-effective. The non-wood’s sources are from agricultural waste which has lesser environmental impact than wood-sourced microcrystalline cellulose. New production techniques to produce microcrystalline cellulose from non-wood are underway to manufacture. Additionally, non-wood sources are cheaper than wood sources and easily available. Hence, the overall manufacturing of microcrystalline cellulose cost is lower for non-wood-based microcrystalline cellulose, resulting in cheaper end-product. Thus lowering in price of microcrystalline cellulose will significantly create more opportunities for the further growth of the market.
North America is expected to witness significant growth in the global microcrystalline cellulose market due to the continuous advancements and innovation in technologies and the presence of major urbanization centers like Mexico, New York in this region. Asia Pacific is also expected to have the fastest growth in the microcrystalline cellulose market owing to the rising growth of the pharmaceutical industry especially in Japan, China and India. For example; China is the world’s second-largest market for pharmaceuticals and the fastest emerging market for the sector. And, Microcrystalline cellulose is a commonly used excipient in the pharmaceutical industry owing to its excellent compressibility properties. Thus, high growth of the pharmaceutical industry I this region is expected to foster the demand for Microcrystalline cellulose.
Europe is expected to have positive growth in the global microcrystalline cellulose market owing to the growing investments in drug research & development activities and the continuous efforts of pharmaceutical companies to offer superior-quality products in this region.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 976.4 Million|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 1440.3 Million|
|Tables, Charts & Figures:||175|
|microcrystalline cellulose Manufacturers||DowDuPont, Asahi Kasei Chemicals Corporation, Avantor Performance Materials Inc., Accent Microcell Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., DFE Pharma GmbH & Co.Kg, The Dow Chemical Company, Foodchem International Corporation, Gujarat Micro wax Limited, Huzhou City Linghu Xinwang Chemical Co., Ltd., JRS Pharma GmbH & Co. Kg., others|
|Segments Covered||By Source Types, By Applications|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
Middle East and Africa